BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The BioCalendar - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The BioCalendar
X-ORIGINAL-URL:https://thebiocalendar.com
X-WR-CALDESC:Events for The BioCalendar
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260526
DTEND;VALUE=DATE:20260530
DTSTAMP:20260528T103322
CREATED:20260520T124647Z
LAST-MODIFIED:20260520T124647Z
UID:10497-1779753600-1780099199@thebiocalendar.com
SUMMARY:ABFO National Conference
DESCRIPTION:The ABFO National Conference is the leading event for Bioscience CFOs and senior finance professionals aspiring to be CFOs. \nJoin us to gain insights from industry thought leaders and discover why attendees return year after year. \n\n\n\n\n\n\nWho should attend? \n\nCFOs: As the biotech landscape evolves at unprecedented speed\, CFOs find themselves at the center of transformation—not only managing capital\, but shaping strategic direction. At ABFO\, financial leaders will gain critical insights into emerging funding dynamics\, M&A priorities and regulatory shifts that directly influence long term financial planning. You will walk away with a clearer understanding of how to balance innovation investment with disciplined fiscal governance\, how to position your organization in a competitive capital market\, and how to leverage partnerships\, data\, and operational models that accelerate growth. Ultimately\, ABFO equips CFOs with the strategic foresight and practical tools needed to guide their companies through the next wave of scientific and market opportunity. \nAspiring CFOs: For future CFOs\, ABFO offers a front row seat to the forces shaping the industry—and a clear view of the skills and strategic mindset required to lead in it. Attendees will gain exposure to evolving capital raising models and the financial frameworks that drive biotech from early discovery through commercialization. They’ll see firsthand how seasoned CFOs navigate uncertainty\, build investor confidence\, and translate complex science into clear value narratives.\nMore importantly\, aspiring CFOs will leave with a deeper understanding of the competencies they must hone: strategic financial planning in a high risk\, high reward environment; cross functional collaboration with R&D and clinical teams; and the ability to anticipate regulatory\, market\, and operational pressures before they materialize. The conference serves not just as an educational experience\, but as a roadmap—illuminating the path toward becoming a financial leader who can guide a biotech organization through growth\, challenges\, and breakthrough moments.
URL:https://thebiocalendar.com/event/abfo-national-conference/
LOCATION:Philadelphia\, Philadelphia\, PA\, United States
CATEGORIES:Annual Meeting
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260528
DTEND;VALUE=DATE:20260603
DTSTAMP:20260528T103322
CREATED:20260311T084731Z
LAST-MODIFIED:20260311T084731Z
UID:10011-1779926400-1780444799@thebiocalendar.com
SUMMARY:BIO Partnering for Oncology
DESCRIPTION:Connect with innovators\, investors\, and companies advancing cancer breakthroughs\, in person or virtually\, during Chicago’s biggest oncology event through the BIO Partnering™ system.
URL:https://thebiocalendar.com/event/bio-partnering-for-oncology/
LOCATION:Chicago\, Chicago\, IL\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260528T090000
DTEND;TZID=America/Los_Angeles:20260528T103000
DTSTAMP:20260528T103322
CREATED:20260506T135003Z
LAST-MODIFIED:20260506T135003Z
UID:10385-1779958800-1779964200@thebiocalendar.com
SUMMARY:The Art of Fundraising
DESCRIPTION:Danforth Health provides the life sciences community with strategic and operational support across business\, clinical and commercial functions. \nModerated by: Barb Carlin\, CPA\, MBA\, Managing Director\, Mid Atlantic Region\, Danforth Health \n\n 9:00 AM – 10:00 AM – Panel Discussion\n10:00 AM – 10:30 AM – Networking in Zoom Breakout Rooms\n\nQuestions? Contact Lauren Boyle\, lboyle@lifesciencespa.org
URL:https://thebiocalendar.com/event/the-art-of-fundraising-4/
LOCATION:Online webinar
CATEGORIES:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260528T110000
DTEND;TZID=America/Los_Angeles:20260528T120000
DTSTAMP:20260528T103322
CREATED:20260505T121715Z
LAST-MODIFIED:20260522T083133Z
UID:10346-1779966000-1779969600@thebiocalendar.com
SUMMARY:Quality by Design: The Future of Automated Pharmaceutical Labeling
DESCRIPTION:Pharmaceutical labeling continues to change and adapt to trends in product presentation & regulations. Considering trends in automation\, product handling\, and robotics\, it is important to have standardized approaches to pharmaceutical labeling platforms. Rising trends in single use autoinjector devices and personalized medicines require quality design with the future in mind. Pharmaceutical labeling machines need to ensure compatibility with future formats and this is critical to streamline production efforts. Automating labeling processes with robotics for small batches gives manufacturers greater efficiency and removes labor intensive loading and unloading\, as well as possible quality errors from manual feeding and inspection. Learn how HERMA has standard labeling platforms for small to large batch pharmaceutical production\, and everything in between. \nKey Learning Objectives:\n– Understand how Quality by Design (QbD) principles can be applied to pharmaceutical labeling to ensure scalability\, compliance\, and future format compatibility\n– Learn how automation and robotics improve efficiency\, reduce manual errors\, and support small-batch and personalized medicine production\n– Explore standardized labeling platform strategies that enable flexible deployment across varying batch sizes and product formats
URL:https://thebiocalendar.com/event/quality-by-design-the-future-of-automated-pharmaceutical-labeling/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/05/05-28-26-Herma-eBlast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260528T110000
DTEND;TZID=America/Los_Angeles:20260528T120000
DTSTAMP:20260528T103322
CREATED:20260505T144000Z
LAST-MODIFIED:20260522T083108Z
UID:10356-1779966000-1779969600@thebiocalendar.com
SUMMARY:Downstream Decisions To Maximize Vector Yields And Reduce COGs
DESCRIPTION:Gene therapies are among the most expensive biopharmaceuticals to develop and manufacture\, due in large part to persistent bottlenecks in downstream processing. When purification workflows lose 10% to 30% of vector at each unit operation\, it forces developers to make critical tradeoffs to maximize yield without compromising product quality. \nJoin Bioprocess Online on Thursday\, May 28\, at 11 a.m. Eastern for a live panel discussion with Hung Trinh\, Ph.D.\, CEO at Vertex Biopharm Consulting\, and Nathalie Clément\, Ph.D.\, senior VP of vector development at Siren Biotechnology. These experts will explore how teams are finding success overcoming challenges in downstream purification\, as well as how factors like vector type\, dose\, and route of administration can influence downstream design. \nThey will also address evolving regulatory expectations\, including recent FDA and EMA perspectives\, and what they mean for process validation\, analytics\, and commercial readiness.
URL:https://thebiocalendar.com/event/downstream-decisions-to-maximize-vector-yields-and-reduce-cogs/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/05/26_05_BPOL_LinkedIn_1280x720.png
END:VEVENT
END:VCALENDAR